Clinical Trial Update: A Study to Assess Growth in Children With Idiopathic Short Stature

View source ↗

Summary

BioMarin is recruiting for a study to assess growth in children with idiopathic short stature.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Idiopathic Short Stature | Status: RECRUITING